Chemist + Druggist is part of Pharma Intelligence UK Limited

This is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.


This copy is for your personal, non-commercial use. Please do not redistribute without permission.

Printed By

UsernamePublicRestriction

Benjamin D'Montigny: Man versus machine

Automation is rendering roles in the pharmacy team obsolete, says Benjamin D’Montigny

It is sometimes enlightenening - and sometimes frightening - to look at how far the world of pharmacy has come. The Sumerians wrote the earliest surviving prescriptions nearly 5,000 years ago and, needless to say, we have progressed a tad since then.

 

Skip forwards a few thousand years, and things are done slightly differently. No longer are we brewing potions and elixirs, favouring the more prudent methods of aseptic production and automated manufacturing. What was theory and belief is now scientifically tested evidence. And, as we progress and develop in pharmacy, so does the technology we use.

 

Now we stand at a new frontier, one where the need for human hands is lessening and where robotics and logistical optimisation could easily supersede the standard processes that are used in pharmacy currently.

 

This begs the question: what are we dispensers, technicians and pharmacists needed for any more?

 

As a dispenser, there’s no way I could compete with the speed, efficiency or stamina of a dispensing robot that doesn’t make mistakes, never slows down or gets tired. At 150 prescriptions an hour - the stated capacity of one small robotic system - I’d have trouble competing with a machine.

 

In east Kent, William Harvey Hospital has an out-of-hours dispensing service that can be operated remotely to dispense medication for a patient and send it to a safebox elsewhere in the hospital without the pharmacist on duty even leaving the comfort of their own home.

 

Suddenly, the bread and butter of a pharmacist’s day – checking – is made redundant. Dispensers lose their namesake profession. Technicians move to robotic troubleshooting and maintenance rather than actual work with medication.

 

When you look at it this way, you can start to see the appeal of internet pharmacies and hub pharmacy structures that can take on this workload and do it to a higher, more cost-effective standard. Yes, there’s an initial upfront cost - but when you consider the cost of hiring the equivalent in staff power, it is extremely reasonable not to mention the whole myriad of other savings.

 

Dispensaries could easily become a phone or internet service into which humans have the minimal amount of input, reducing the chance of errors to next to nothing and at a speed that is far superior to that of a team of trained, experienced dispensers. The prospect could be something similar to Amazon with next day delivery and free shipping.

 

Maybe it’s time to consider retraining?


Benjamin D’Montigny is a locum dispenser working in the south of England

 

More from Benjamin D'Montigny

 

Where do you think the future of the profession lies?

We want to hear your views, but please express them in the spirit of a constructive, professional debate. For more information about what this means, please click here to see our community principles and information

Topics

         
Pharmacist Manager
Barnsley
£30 per hour

Apply Now
Latest News & Analysis
See All
UsernamePublicRestriction

Register

CD000760

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel